Glaukos (GKOS) Research & Development (2014 - 2026)

Glaukos (GKOS) has 13 years of Research & Development data on file, last reported at $44.1 million in Q1 2026.

• Quarterly Research & Development rose 36.45% year-over-year to $44.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $162.4 million (up 17.64% YoY) and the FY2025 annual result came in at $150.6 million, up 10.4% from the prior year.
• Research & Development climbed to $44.1 million in Q1 2026 per GKOS's latest filing, from $43.7 million in the prior quarter.
• Across five years, Research & Development topped out at $44.1 million in Q1 2026 and bottomed at $26.9 million in Q1 2022.
• The 5-year median for Research & Development is $34.7 million (2024), against an average of $34.9 million.
• The widest annual swing landed in 2024, when Research & Development declined 12.64%; it then jumped 36.45% in 2026.
• Tracing GKOS's Research & Development over 5 years: stood at $35.8 million in 2022, then gained by 3.49% to $37.1 million in 2023, then retreated by 1.44% to $36.5 million in 2024, then grew by 19.5% to $43.7 million in 2025, then grew by 1.13% to $44.1 million in 2026.
• Per Business Quant, the three latest GKOS Research & Development figures stand at $44.1 million (Q1 2026), $43.7 million (Q4 2025), and $38.1 million (Q3 2025).

Peer Comparison